• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Analysis of variation in PF83, an erythrocytic merozoite vaccine candidate antigen of Plasmodium falciparum.

作者信息

Thomas A W, Waters A P, Carr D

机构信息

Department of Immunology, Walter Reed Army Institute of Research, Washington DC 20307-5100.

出版信息

Mol Biochem Parasitol. 1990 Sep-Oct;42(2):285-7. doi: 10.1016/0166-6851(90)90172-i.

DOI:10.1016/0166-6851(90)90172-i
PMID:2270110
Abstract
摘要

相似文献

1
Analysis of variation in PF83, an erythrocytic merozoite vaccine candidate antigen of Plasmodium falciparum.恶性疟原虫红细胞内期裂殖子疫苗候选抗原PF83的变异分析
Mol Biochem Parasitol. 1990 Sep-Oct;42(2):285-7. doi: 10.1016/0166-6851(90)90172-i.
2
Differential localization of full-length and processed forms of PF83/AMA-1 an apical membrane antigen of Plasmodium falciparum merozoites.恶性疟原虫裂殖子顶端膜抗原PF83/AMA-1全长形式和加工形式的差异定位
Mol Biochem Parasitol. 1994 Sep;67(1):59-68. doi: 10.1016/0166-6851(94)90096-5.
3
Diversity of Plasmodium falciparum vaccine candidate merozoite surface protein 4 (MSP4) in a natural population.恶性疟原虫疫苗候选抗原裂殖子表面蛋白4（MSP4）在自然群体中的多样性。
Mol Biochem Parasitol. 2004 Apr;134(2):275-80. doi: 10.1016/j.molbiopara.2003.12.005.
4
Limited polymorphism of the vaccine candidate merozoite surface protein 4 of Plasmodium falciparum.恶性疟原虫候选疫苗裂殖子表面蛋白4的多态性有限。
Mol Biochem Parasitol. 2002 Apr 9;120(2):301-3. doi: 10.1016/s0166-6851(01)00457-1.
5
Diversity of the vaccine candidate AMA-1 of Plasmodium falciparum.恶性疟原虫疫苗候选抗原AMA-1的多样性。
Mol Biochem Parasitol. 1996 Apr;77(1):109-13. doi: 10.1016/0166-6851(96)02583-2.
6
[Var gene family and antigen variation in Plasmodium falciparum].[恶性疟原虫的可变基因家族与抗原变异]
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2010 Apr;28(2):153-6.
7
Towards a malaria vaccine: what is in sight?迈向疟疾疫苗：前景如何？
Allergol Immunopathol (Madr). 1991 May-Jun;19(3):129-35.
8
Conservation of structural motifs and antigenic diversity in the Plasmodium falciparum merozoite surface protein-3 (MSP-3).
Mol Biochem Parasitol. 1997 Dec 1;90(1):21-31. doi: 10.1016/s0166-6851(97)00130-8.
9
Molecular variation in Plasmodium falciparum: polymorphic antigens of asexual erythrocytic stages.
Acta Trop. 1993 May;53(3-4):239-53. doi: 10.1016/0001-706x(93)90032-7.
10
Analysis of sequence diversity in the Plasmodium falciparum merozoite surface protein-1 (MSP-1).恶性疟原虫裂殖子表面蛋白1（MSP-1）的序列多样性分析。
Mol Biochem Parasitol. 1993 May;59(1):1-14. doi: 10.1016/0166-6851(93)90002-f.

引用本文的文献

1
The role of different components of the immune system against Plasmodium falciparum malaria: Possible contribution towards malaria vaccine development.免疫系统不同成分对恶性疟原虫疟疾的作用：对疟疾疫苗开发的可能贡献。
Mol Biochem Parasitol. 2021 Nov;246:111425. doi: 10.1016/j.molbiopara.2021.111425. Epub 2021 Oct 16.
2
Antibodies Against the Apical Membrane Antigen 1 From the Belem Strain Share Common Epitopes Among Other Worldwide Variants.针对贝伦株顶端膜抗原 1 的抗体与其他世界各地变异株存在共同表位。
Front Cell Infect Microbiol. 2021 Mar 16;11:616230. doi: 10.3389/fcimb.2021.616230. eCollection 2021.
3
Structure and function of a malaria transmission blocking vaccine targeting Pfs230 and Pfs230-Pfs48/45 proteins.
疟疾传播阻断疫苗靶向 Pfs230 和 Pfs230-Pfs48/45 蛋白的结构与功能。
Commun Biol. 2020 Jul 24;3(1):395. doi: 10.1038/s42003-020-01123-9.
4
Identification of adjuvants for clinical trials performed with Plasmodium falciparum AMA1 in rabbits.鉴定用兔疟原虫 AMA1 进行临床试验的佐剂。
BMC Immunol. 2019 Jul 30;20(1):25. doi: 10.1186/s12865-019-0307-y.
5
Variations in the quality of malaria-specific antibodies with transmission intensity in a seasonal malaria transmission area of Northern Ghana.加纳北部季节性疟疾传播地区疟疾特异性抗体质量随传播强度的变化
PLoS One. 2017 Sep 25;12(9):e0185303. doi: 10.1371/journal.pone.0185303. eCollection 2017.
6
Immune Responses in Malaria.疟疾中的免疫反应
Cold Spring Harb Perspect Med. 2017 Aug 1;7(8):a025577. doi: 10.1101/cshperspect.a025577.
7
Immunization with apical membrane antigen 1 confers sterile infection-blocking immunity against Plasmodium sporozoite challenge in a rodent model.经顶端膜抗原 1 免疫接种可在啮齿动物模型中针对疟原虫子孢子挑战产生无菌感染阻断免疫。
Infect Immun. 2013 Oct;81(10):3586-99. doi: 10.1128/IAI.00544-13. Epub 2013 Jul 8.
8
Defining the antigenic diversity of Plasmodium falciparum apical membrane antigen 1 and the requirements for a multi-allele vaccine against malaria.定义恶性疟原虫顶膜抗原 1 的抗原多样性和多等位基因疟疾疫苗的需求。
PLoS One. 2012;7(12):e51023. doi: 10.1371/journal.pone.0051023. Epub 2012 Dec 5.
9
Measurement of the plasma levels of antibodies against the polymorphic vaccine candidate apical membrane antigen 1 in a malaria-exposed population.测量疟疾暴露人群中针对多态疫苗候选物顶膜抗原 1 的抗体血浆水平。
BMC Infect Dis. 2012 Feb 2;12:32. doi: 10.1186/1471-2334-12-32.
10
Safety and immunogenicity of multi-antigen AMA1-based vaccines formulated with CoVaccine HT™ and Montanide ISA 51 in rhesus macaques.用 CoVaccine HT™ 和 Montanide ISA 51 配制的多抗原 AMA1 基疫苗在恒河猴中的安全性和免疫原性。
Malar J. 2011 Jul 4;10:182. doi: 10.1186/1475-2875-10-182.